Advertisement

International Journal of Hematology

, Volume 73, Issue 3, pp 393–398 | Cite as

Antithrombotic Effects of Tetramethylpyrazine in In Vivo Experiments

  • Joen R. Sheu
  • George Hsiao
  • Yen M. Lee
  • Mao H. Yen
Case Report

Abstract

In this study, tetramethylpyrazine (TMPZ) was effective in reducing the mortality of ADP-induced acute pulmonary thromboembolism in mice when administered intravenously at doses of 40 and 80 μg/g. In addition, intravenous injection of TMPZ (10 μg/g) significantly prolonged the bleeding time by approximately 1.5-fold compared with normal saline in severed mesenteric arteries of rats. Continuous infusion of TMPZ (1 μg/g per min) for 10 minutes also significantly increased the bleeding time approximately 1.6-fold, and the bleeding time returned to baseline within 60 minutes after cessation of TMPZ infusion. On the other hand, platelet thrombi formation was induced by irradiation of mesenteric venules with filtered light in mice pretreated intravenously with fluorescein sodium (10 μg/kg). When it was intravenously injected, TMPZ (250 μg/g) significantly prolonged the latent period of the induction of platelet plug formation in mesenteric venules. TMPZ (250 μg/g) prolonged occlusion time approximately 1.4-fold (183 +- 18 seconds) compared with that of normal saline (132 +- 14 seconds). Furthermore, aspirin (300 μg/g) showed similar activity in the prolongation of occlusion time in this experiment. In conclusion, these results suggest that TMPZ has effective antithrombotic activity in vivo and may be a potential therapeutic agent for arterial thrombosis but must be assessed further for toxicity.

Key words

Tetramethylpyrazine Fluorescein sodium Occlusion time Platelet plug formation Arterial thrombosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Beijing Institute of Pharmaceutical Industry. Studies of active components of Ligusticum Wallichii Franch. I. Extraction, isolation and structure identification of tetramethylpyrazine.Chin Med J. 1977;7:420–421.Google Scholar
  2. 2.
    Beijing Institute of Pharmaceutical Industry. Studies of active components of Ligusticum Wallichii Franch. III. A report of the treatment of tetramethylpyrazine in 218 patients with ischemia cerebrovascular diseases.Chin Med J. 1977;8:467–469.Google Scholar
  3. 3.
    Chen KJ, Chen K. Ischemic stroke treated with Ligusticum chuanxiong.Chin Med J. 1992;105:870–873.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Lu CS, Yin HM, Hung YH, Pao C, Sung CF. Radix Salviae Mitiorrhizae and Rhizoma Ligustici Wallichii in coronary heart disease.Chin Med J. 1978;4:43–46.Google Scholar
  5. 5.
    Wang WF. Changes of nailfold microcirculation in 28 cases of acute cerebral thrombosis treated with Ligustrazine (original in Chinese).Chin J Neurol Psychiatry. 1984;17:121–124.Google Scholar
  6. 6.
    Ho WKK,Web HL, Lee CM. Tetramethylpyrazine for treatment of experimentally induced stroke in Mongolian gerbils.Stroke. 1989;20:96–99.CrossRefGoogle Scholar
  7. 7.
    Ojewole JAO. Blockade of adrenergic and cholinergic transmissions by tetramethylpyrazine.Planta Med. 1981;43:1–10.CrossRefPubMedGoogle Scholar
  8. 8.
    Beijing Institute of Pharmaceutical Industry. Pharmacological studies on tetramethylpyrazine.Chin Med J. 1977;4:319–322.Google Scholar
  9. 9.
    Sheu JR, Kan YC, Hung WC, Ko WC, Yen MH. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets.Thromb Res. 1997;88:259–270.CrossRefPubMedGoogle Scholar
  10. 10.
    Sheu JR, Kan YC, Hung WC, Lin CH, Yen MH. The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase.Life Sci. 2000;67:937–947.CrossRefPubMedGoogle Scholar
  11. 11.
    Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.Lancet. 1989;2:1215–1220.CrossRefGoogle Scholar
  12. 12.
    Hass WK, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients.N Engl J Med. 1989;321:501–507.CrossRefPubMedGoogle Scholar
  13. 13.
    Sato M, Ohshima N. Platelet thrombus induced in vivo by filtered light and fluorescent dye in mesenteric microvessels of the rat.Thromb Res. 1984;35:319–334.CrossRefPubMedGoogle Scholar
  14. 14.
    Sheu JR, Chao SH, Yen MH, Huang TF. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.Thromb Haemost. 1994;72:617–621.PubMedGoogle Scholar
  15. 15.
    Sheu JR, Yen MH, Peng IC, Chang MC, Huang TF. Triflavin, an Arg-Gly-Asp-containing peptide, prevents platelet plug formation in in vivo experiments.Eur J Pharmacol. 1995;294:231–238.CrossRefPubMedGoogle Scholar
  16. 16.
    Ojewole JAO, Odebiyi OO. Neuromuscular and cardiovascular actions of tetramethylpyrazine from the stem Jatropha Podagrica.Planta Med. 1980;38:332–338.CrossRefPubMedGoogle Scholar
  17. 17.
    Dai XZ, Bache RJ. Coronary and systemic hemodynamic effects of tetramethylpyrazine in the dog.J Cardiovasc Pharmacol. 1985;7:841–849.CrossRefPubMedGoogle Scholar
  18. 18.
    Tuttue RS, Marmelstein L, Trad T, Reddy S, Radley T. In vitro uterine response to tetramethylpyrazine, the active constituent of Chung Chong (a traditional Chinese medicine).Am J Obstet Gynecol. 1989;161:1319–1323.CrossRefGoogle Scholar
  19. 19.
    Nordoy A, Chandler AB. Platelet thrombosis induced by adenosine diphosphate in the rat.Scand J Haematol. 1964;1:16–25.CrossRefGoogle Scholar
  20. 20.
    Rodgers RPCX, Levin J. A critical reappraisal of the bleeding time.Semin Thromb Hemost. 1990;16:1–20.CrossRefPubMedGoogle Scholar
  21. 21.
    Sheu JR, Hung WC, Wu CH, et al. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia.Circulation. 1999;99:3056–3062.CrossRefPubMedGoogle Scholar
  22. 22.
    Sheu JR,Yen MH, Hung WC, Lee YM, Su CH, Huang TF. Triflavin inhibits platelet-induced vasocontraction in deendothelialized aorta.Arterioscler Thromb Vasc Biol. 1997;17:3461–3468.CrossRefPubMedGoogle Scholar
  23. 23.
    Callahan AB, Lutz BR, Fulton GP, Degelman J. Smooth muscle and thrombus thresholds to unipolar stimulation of small blood vessels.Angiology. 1960;11:35–39.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2001

Authors and Affiliations

  • Joen R. Sheu
    • 1
    • 2
  • George Hsiao
    • 2
  • Yen M. Lee
    • 3
  • Mao H. Yen
    • 3
  1. 1.Graduate Institute of Medical SciencesTaiwan
  2. 2.Department of PharmacologyTaipei Medical UniversityTaipeiTaiwan
  3. 3.Department of PharmacologyNational Defense Medical CenterTaipeiTaiwan

Personalised recommendations